FMS vs. SNN: Fresenius Medical Care vs. Smith & Nephew Stock Comparison

Company Profile

Fresenius Medical Care (FMS) and Smith & Nephew (SNN) both fall under the Health Care Equipment & Services industry group, but FMS is classified in Health Care Providers & Services while SNN is classified in Health Care Equipment & Supplies.

Both Fresenius Medical Care (FMS) and Smith & Nephew (SNN) trade as ADRs — their core financials are comparable, but keep FX, depositary-program fees, and dividend withholding in view for each.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Fresenius Medical Care (FMS) at 7.84% and Smith & Nephew (SNN) at 11.85% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Smith & Nephew (SNN) at 10.08% retains a top-quartile share of revenue as profit, ahead of Fresenius Medical Care (FMS) at 4.22%, which keeps about the industry-typical share.

Smith & Nephew (SNN) at 14.47% operates in the top operating margin quartile, ahead of Fresenius Medical Care (FMS) at 9.63%, which runs around its industry’s norm.

Profitability Metrics

Growth

Smith & Nephew (SNN) at 6.09% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Both Fresenius Medical Care (FMS) at 83.61% and Smith & Nephew (SNN) at 52.34% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

Growth Metrics

Financial Strength

Smith & Nephew (SNN) at 2.14 keeps current ratio within its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for FMS.

Both Fresenius Medical Care (FMS) at 0.79 and Smith & Nephew (SNN) at 0.73 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Both Fresenius Medical Care (FMS) at 6.30% and Smith & Nephew (SNN) at 1.24% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Both Fresenius Medical Care (FMS) at 50.14% and Smith & Nephew (SNN) at 53.20% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while Smith & Nephew (SNN) at 21.19 is closer to its industry’s usual earnings multiple — a discount for FMS, though growth and earnings durability still matter.

Fresenius Medical Care (FMS) at 0.62 sits in the cheaper P/S ratio quartile while Smith & Nephew (SNN) at 2.07 prices around its industry’s middle — FMS costs less per dollar of sales, though read it alongside growth and margins.

Fresenius Medical Care (FMS) at 0.85 sits in the lower P/B ratio quartile relative to book while Smith & Nephew (SNN) at 12.80 prices above its industry range — a wide valuation gap against assets.

Valuation Metrics